RPT Q1 2026 Earnings Significant EPS Miss Stock Declines LNT Q1 2026 Earnings Earnings Beat Expectations with 712 Surprise CLOV Q1 2026 Earnings Strong EPS Surprise of 12876 Amid Revenue Uncertainty Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress SU Q1 2026 Earnings Strong EPS Beat Reflects Operational Discipline TXNM Q1 2026 Earnings EPS Miss of 314 Disappoints Stock Edges Lower